Ciclesonide

C₃₂H₄₄O₇

540.69

MFCD00866004

NA.24

Ciclesonide is a new-generation, non-halogenated glucocorticoid. It is a prodrug that releases an active primary metabolite, ciclesonide−active principle (CIC-AP), on enzymatic cleavage.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets, have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Ciclesonide EP reference standard is used as a pharmaceutical primary standard to quantify the analyte in pharmaceutical formulations, bulk drug and metered-dose inhalers (MDIs) and dry powder ciclesonide inhalers using liquid chromatography (LC) based techniques.

Please find SDS provided by EDQM here..

Sales restrictions may apply.

synthetic

pharmaceutical primary standard

EP

EDQM

protect from light

white

665.0 ℃/1.333 hPa (1229.0°F)

209-211 ℃ (408—412°F)

water: <0.1 g/L
acetone: soluble
ethanol: soluble

1.23 g/cm³ at 20 ℃ (1.333 hPa)

pharmaceutical (small molecule)

neat

ambient

2-8℃

C[C@@]12C(CC[C@]3([H])[C@]2([H])[C@@H](O)C[C@@]4(C)[C@@]3([H])C[C@]5([H])[C@]4(O[C@@](C6CCCCC6)([H])O5)C(COC(C(C)C)=O)=O)=CC(C=C1)=O

1S/C32H44O7/c1-18(2)28(36)37-17-25(35)32-26(38-29(39-32)19-8-6-5-7-9-19)15-23-22-11-10-20-14-21(33)12-13-30(20,3)27(22)24(34)16-31(23,32)4/h12-14,18-19,22-24,26-27,29,34H,5-11,15-17H2,1-4H3/t22-,23-,24-,26+,27+,29+,30-,31-,32+/m0/s1

LUKZNWIVRBCLON-GXOBDPJESA-N

Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

13 - Non Combustible Solids

WGK 3